β-amyloid drug
Evidence from:
primary |
all sources
Related entities (6)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| APP | regulates | β-amyloid | — | 1 |
| ECM | interacts_with | β-amyloid | — | 1 |
| extracellular matrix | interacts_with | β-amyloid | — | 1 |
| β-amyloid | biomarker_for | Alzheimer's disease | — | 1 |
| β-amyloid | associated_with | amyloid plaques | — | 1 |
| β-secretase | regulates | β-amyloid | — | 1 |
Mentioned in (4)
Papers in which this entity is mentioned.
- ApoE Regulates the Development of Adult Newborn Hippocampal Neurons. (2018)
- Early pathogenic event of Alzheimer's disease documented in iPSCs from patients with PSEN1 mutations. (2017)
- Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes. (2016)
- Molecular insights into the pathogenesis of Alzheimer's disease and its relationship to normal aging. (2011)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| β-amyloid | drug | 4 | 6 |